Hostname: page-component-586b7cd67f-dsjbd Total loading time: 0 Render date: 2024-11-22T14:14:40.398Z Has data issue: false hasContentIssue false

[No Title]

Published online by Cambridge University Press:  29 January 2018

M. R. Lowe
Affiliation:
Basildon Hospital, Basildon, Essex
D. H. Batchelor
Affiliation:
Janssen Pharmaceutical Ltd, Wantage
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Copyright
Copyright © 1986 The Royal College of Psychiatrists 

References

Baastrup, P. C., Hollnagel, P., Sorensen, R. & Schou, M. (1976) Adverse reactions in treatment with lithium carbonate and haloperidol. Journal of the American Medical Association, 236, 26452646.Google Scholar
Cohen, W. J. & Cohen, N. H (1974) Lithium carbonate, haloperidol and irreversible brain damage. Journal of the American Medical Association, 230, 12831287.Google Scholar
Frankel, M. H. & Spring, G. K. (1982) Questions about combined lithium and haloperidol treatment. American Journal of Psychiatry, 139, 537.Google Scholar
Hone, M. P., Lowe, M. R. & Batchelor, D. H. (1985) Reported neurotoxicity with the lithium/haloperidol combination – A literature review. World Psychiatric Association Regional Symposium, Athens, Greece. Abstracts – p 108.Google Scholar
Jeeferson, J. W. & Greist, J. H. (1980) Haloperidol and lithium: Their combined use and the issue of their compatibility. In Haloperidol Update: 1958–1980 7, 7382 (ed. Ayd, F. J.) Baltimore: Ayd Medical Communications.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.